Topics
pancreasAnatomical structure
Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherap
Journal Article;Pancreatic cancer remains an aggressive disease with a 5 year survival rate of 5%. O...
Pancreatic adenocarcinoma is the fifth leading cause of cancer-related death in the U.S. In spite of...
Adjuvant therapy represents the gold standard treatment for radically resected pancreatic cancer. Re...
Abstract Background Acinar cell carcinoma (ACC) represents only 1–2% of pancreatic cancers and is a ...
Purpose: The objective of this study was to determine the effect on resection rate and survival of n...
The objective of this study was to determine the effect on resection rate and survival of neoadjuvan...
Background Acinar cell carcinoma (ACC) is a very rare malignancy and represents only 1% to 2% of pan...
The objective of this study was to determine the effect on resection rate and survival of neoadjuvan...
Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without y of life the e...
PURPOSE: Acinar cell carcinomas (ACCs) are a rare pancreatic tumor group with no standardized treatm...
<p><b>Copyright information:</b></p><p>Taken from "Pancreatectomy for non-pancreatic malignancies re...
Acinar cell carcinoma (ACC) of the pancreas is a rare malignancy making up approximately 1% of pancr...
Surgical resection is the only chance for cure of pancreatic cancer. Unfortunately, the majority of ...
This manuscript summarized one section out of the international symposium, Pancreatic Cancer 2012, w...
AbstractPancreatic carcinoma is a malignancy with a poor prognosis and the 4th. most common cause of...
Journal Article;Pancreatic cancer remains an aggressive disease with a 5 year survival rate of 5%. O...
Pancreatic adenocarcinoma is the fifth leading cause of cancer-related death in the U.S. In spite of...
Adjuvant therapy represents the gold standard treatment for radically resected pancreatic cancer. Re...
Abstract Background Acinar cell carcinoma (ACC) represents only 1–2% of pancreatic cancers and is a ...
Purpose: The objective of this study was to determine the effect on resection rate and survival of n...
The objective of this study was to determine the effect on resection rate and survival of neoadjuvan...
Background Acinar cell carcinoma (ACC) is a very rare malignancy and represents only 1% to 2% of pan...
The objective of this study was to determine the effect on resection rate and survival of neoadjuvan...
Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without y of life the e...
PURPOSE: Acinar cell carcinomas (ACCs) are a rare pancreatic tumor group with no standardized treatm...
<p><b>Copyright information:</b></p><p>Taken from "Pancreatectomy for non-pancreatic malignancies re...
Acinar cell carcinoma (ACC) of the pancreas is a rare malignancy making up approximately 1% of pancr...
Surgical resection is the only chance for cure of pancreatic cancer. Unfortunately, the majority of ...
This manuscript summarized one section out of the international symposium, Pancreatic Cancer 2012, w...
AbstractPancreatic carcinoma is a malignancy with a poor prognosis and the 4th. most common cause of...
Journal Article;Pancreatic cancer remains an aggressive disease with a 5 year survival rate of 5%. O...
Pancreatic adenocarcinoma is the fifth leading cause of cancer-related death in the U.S. In spite of...
Adjuvant therapy represents the gold standard treatment for radically resected pancreatic cancer. Re...
Add to ORKG